´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, À¯Åë ä³Îº°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Diet Pills Market Share, Size, Trends, Industry Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements); By Distribution Channel; By Application; By Region; Segment Forecast, 2023-2032
»óǰÄÚµå : 1338867
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,046,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,468,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,891,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠ¿¬±¸¿¡ µû¸£¸é, ¼¼°è ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 33¾ï 9,953¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

´ÙÀÌ¾îÆ® ÇÊ¿¡ ´ëÇÑ ¼ö¿ä´Â Á¤ºÎÀÇ ºñ¸¸ ´ëÃ¥¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ºÒÇÕ¸®ÇÑ Ã¼Áß Áõ°¡, ´ç´¢º´, ºñ¸¸°ú °°Àº ¹®Á¦ÀÇ È®»êÀº ´ÙÀÌ¾îÆ® ÇÊÀÇ ÆÇ¸Å¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æ ¹× °Ç°­ÁõÁø±¹¿¡ µû¸£¸é ¹Ì±¹ ¾î¸°ÀÌ¿Í ¼ºÀÎ 5¸í Áß 1¸í, ¼ºÀÎ 5¸í Áß 2¸íÀÌ ºñ¸¸À̸ç, ´õ ¸¹Àº »ç¶÷µéÀÌ °úüÁßÀ̶ó°í ÇÕ´Ï´Ù. Healthy People 2030ÀÇ ¸ñÇ¥´Â °Ç°­ÇÑ ½Ä½À°ü°ú ±ÔÄ¢ÀûÀÎ ¿îµ¿À» Àå·ÁÇÏ¿© °Ç°­ÇÑ Ã¼ÁßÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ´Ù, ½ÉÀ庴, ³úÁ¹Áß, ÀϺΠ¾ÏÀº ºñ¸¸°ú °ü·ÃµÈ ½É°¢ÇÑ °Ç°­ ¹®Á¦ Áß ÀϺο¡ ºÒ°úÇÕ´Ï´Ù. ¿µ¾ç º¸ÃæÁ¦ ó¹æÀÇ Çʿ伺¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ º¸ÃæÁ¦ ¼·ÃëÀÇ ÀαⰡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

ÃÖ±Ù ÇÇÆ®´Ï½º ¾ÖÈ£°¡µéÀÌ ´ÙÀÌ¾îÆ® ÇÊ Ã³¹æ¿¡¼­ ¿µ¾ç»çÀÇ ¿ªÇÒÀ» ÅëÁ¦Çϰí ÀÖ½À´Ï´Ù. ´ÙÀÌ¾îÆ® º¸Á¶Á¦ Á¦Á¶¾÷ü´Â ÀÌ·¯ÇÑ Ãß¼¼¿¡ ÁÖ¸ñÇϰí Àü·«Àû ¸¶ÄÉÆÃ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÇÇÐ ¿¬±¸ ºÐ¾ß°¡ ¹ßÀüÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ´ÙÀÌ¾îÆ® ÇÊ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿©·¯ ±â¾÷ÀÌ ´Ù¾çÇÑ ¿µ¾çÁ¦¸¦ ¼º°øÀûÀ¸·Î ½ÃÀå¿¡ Ãâ½ÃÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ¿þ°íºñ(¸®¶ó±Û·çƼµå) ÁÖ»çÁ¦(2.4mg, ÁÖ 1ȸ)¸¦ ºñ¸¸ ¶Ç´Â üÁß °ü·Ã Àå¾Ö(°íÄÝ·¹½ºÅ×·Ñ, Á¦2Çü ´ç´¢º´ µî)°¡ ÀÖ´Â ¼ºÀο¡¼­ ÀúÄ®·Î¸® ½Ä´Ü ¹× ½Åü Ȱµ¿ °­È­¿Í ÇÔ²² »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ½ÂÀÎÇß½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ºñó¹æ ´ÙÀÌ¾îÆ® ÇÊÀº ÀÇ»çÀÇ Ã³¹æÀü ¾øÀÌ ±¸ÀÔÇϰųª »ç¿ëÇÒ ¼ö ÀÖ´Â °Ç°­º¸Á¶½ÄǰÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦¿¡ ÇÔÀ¯µÈ ¼ººÐÀº Á¾Á¾ ½ÅÁø´ë»ç¸¦ ÃËÁøÇϰí, ¹è°íÇÄÀ» ¾ïÁ¦Çϰí, ź¼öÈ­¹°°ú Áö¹æÀÇ Èí¼ö¸¦ ¹æÁöÇÏ¿© üÁß °¨·®¿¡ µµ¿òÀ» ÁØ´Ù°í ¾à¼ÓÇÕ´Ï´Ù. Ä«ÆäÀÎ, ³ìÂ÷ ÃßÃâ¹°, Å©·Ò, °¡¸£½Ã´Ï¾Æ įº¸Áö¾Æ, Ǫµð¾Æ°ñµå´Ï µîÀº ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â ´ÙÀÌ¾îÆ® ÇÊÀÇ ´ëÇ¥ÀûÀÎ ¼ººÐÀÔ´Ï´Ù. µû¶ó¼­ ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â ¾àǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿ÀÇÁ¶óÀÎ ºÐ¾ß´Â Á¶»ç ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ÙÀÌ¾îÆ® ÇÊÀÇ ´ë¸é ÆÇ¸Å´Â ÀϹÝÀûÀ¸·Î ¼Ò¸ÅÁ¡À̳ª º´¿ø ¾à±¹¿¡¼­ ÀÌ·ç¾îÁý´Ï´Ù.

Çãºê º¸ÃæÁ¦ ºÐ¾ß°¡ Å« ¼öÀÍ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀÔ´Ï´Ù. ´õ ¸¹Àº ºñ°Ç ¹× ½Ä¹°¼º ´ëü ½Ä´Ü¿¡ ´ëÇÑ ¿å±¸°¡ È£ÀÇÀûÀÎ ¼ºÀåÀ¸·Î À̾îÁú °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼ÒºñÀÚÀÇ °Ç°­ ÀÇ½Ä Çâ»ó, °¡Ã³ºÐ ¼Òµæ Áõ°¡, Àα¸ Åë°èÇÐÀû º¯È­·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå, Á¦Ç° À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå, ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå, À¯Åë ä³Îº°

Á¦8Àå ¼¼°èÀÇ ´ÙÀÌ¾îÆ® ÇÊ ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï »óȲ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global diet pills market size is expected to reach USD 3,399.53 million by 2032, according to a new study by Polaris Market Research. The report "Diet Pills Market Share, Size, Trends, Industry Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements); By Distribution Channel; By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diet pill demand is being fueled by government measures to combat obesity. The prevalence of issues, including irrational weight gain, diabetes, and obesity, is anticipated to boost sales of diet pills. According to the Office of Disease Prevention and Health Promotion, In the United States, 1 in 5 children and adults and 2 in 5 adults are obese, while many more are overweight. The goal of Healthy People 2030 is to encourage healthy eating and regular exercise so that people can achieve and keep a healthy weight. Type 2 diabetes, heart conditions, stroke, and some cancers are just a few of the significant health issues that obesity is associated with. The public is becoming more aware of the need for prescriptions for dietary supplements, and there is a spike in the popularity of consuming these supplements.

Nowadays, fitness enthusiasts control nutritionists' role in the prescription of diet medications. Diet pill manufacturers frequently pay some attention to these trends and place a greater emphasis on their goods' strategic marketing. The medical research field is developing, causing the demand for diet pills to increase over the forecast period. Several businesses have successfully introduced a variety of nutritional pills on the market. For instance, in July 2021, Wegovy (liraglutide) injection (2.4 mg once weekly) was approved by the U.S. Food and Drug Administration to be used in conjunction with a low-calorie diet and enhanced physical activity in adult people who are obese or weight-related disorder (such as high cholesterol, type 2 diabetes). Thus, these factors are supporting the growth of the market.

Additionally, non-prescription diet pills are dietary supplements that can be purchased or used without a prescription from a doctor. The components in these supplements frequently promise to aid in weight loss by boosting metabolism, reducing hunger, or preventing the absorption of carbohydrates or fats. Caffeine, green tea extract, chromium, garcinia cambogia, and hoodia gordonii are typical components in over-the-counter diet pills. Therefore, the demand for over-the-counter pills is rising.

Diet Pills Market Report Highlights

The offline segment is projected to grow at a highest CAGR over the study period. In-person sales of diet tablets typically take place in retail establishments and hospital pharmacies.

Herbal supplements segment accounted for significant revenue share. The desire for even more vegan and plant-based diet alternatives is likely to lead to favorable growth.

Asia-Pacific is expected to grow at a significant rate over the projected period due to increasing health consciousness among consumers, increasing disposable income, and demographic changes.

The global players include: Arena Pharmaceuticals, Currax Pharmaceuticals, Chong's Health Care, Cortislim, Novo Nordisk, Nanjing Chang'ao Pharmaceutical, Orexigen Therapeutics, TEVA Pharmaceutical, Vivus, Inc., & Zoller Laboratories

Polaris Market Research has segmented the Diet Pills market report based on product type, application, distribution channel, and region:

Diet Pills, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

Diet Pills, Application Outlook (Revenue - USD Million, 2019 - 2032)

Diet Pills, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Diet Pills, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Diet Pills Market Insights

5. Global Diet Pills Market, by Product Type

6. Global Diet Pills Market, by Application

7. Global Diet Pills Market, by Distribution Channel

8. Global Diet Pills Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â